Merrimack - Articles and news items

First patient enrolled in Phase 2 study of Onivyde in pancreatic adenocarcinoma

Industry news / 27 October 2015 / Victoria White

The start-up of this study resulted in $62.5M of milestone payments to Merrimack from Baxalta…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+